Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
By 2030, the size of the Wound Care Biologics Market will have reached one billion and two hundred million dollars at a CAGR of 10.5% during the 2022-2030 forecast period. Many factors influence the wound care biologics market, thus determining its growth and dynamics. A key driver is the increased prevalence of chronic wounds accompanied by an increasing number of elderly individuals. The wound care biologics market is shaped significantly by technological advances. This contributes to improved effectiveness and higher sophistication levels in terms of the development of more powerful and advanced wound care biologics through continuous innovation in tissue engineering, regenerative medicine, and biotechnology. The adoption of these therapies has been promoted by advanced manufacturing techniques as well as the incorporation of novel biomaterials that have improved properties and therapeutic aspects for these biologics utilized in managing difficult wound cases.
Regulatory concerns play a significant role in shaping the market dynamics for wound care biologics. These standards should be strict enough to ensure safety and efficacy for manufacturers who want to produce these products. Apart from healthcare spending, reimbursement policies are also among the economic factors affecting market dynamics. Advanced wound care biologic integration into daily clinical practice becomes feasible on financial grounds, depending on coverage and reimbursement policies. Different areas face different challenges with geographic disparities affecting the landscape, and they have varied priorities regarding wound management. Distribution varies according to patients' demographics, such as health infrastructure available, disease prevalence, etc., which influences demand for different types of wound care biologic products.
Competitive dynamics contribute towards innovation as well as expansion within the segment concerning Wound Care Biologics markets. The presence of major players influences product development decisions, collaborations being made strategically, and the share each holds in the market. Family practices constantly improve technology on their products while undergoing research under development phases; it is important to note that the evolution of the wound care biologics market is attributed to these R&D activities. Such measures as understanding the way wounds can heal better, defining novel biomarkers, and improving the delivery of biologics make this market more competitive. In addition, awareness campaigns and training also play a significant role in driving growth in this field. Adoption of these biologics increases as healthcare professionals and the general public know about their ability to promote accelerated healing while reducing post-operative complications.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Growth Rate | Â Â 10.50% (2020-2030 |
Wound Care Biologics Market Highlights:
Wound Care Biologics Market overview:
Over the projected period, the wound care biologics market is predicted to increase considerably. In 2017, the wound care biologics market was estimated to be worth USD 1.20 billion, and the market is expected to increase at a CAGR of 10.50% from 2022 to 2030. Wound care biologics products help the body repair wounds naturally by creating an active healing environment. Diabetic ulcers, venous ulcers, arterial ulcers, and pressure ulcers are the most common wounds treated with biologics.
The wound care biologics market is predicted to develop due to reasons such as the rising prevalence of chronic illnesses and burn injuries, as well as rising healthcare spending. According to the Centers for Disease Control and Prevention (CDC), around 2.8 million persons were admitted to hospitals owing to injuries in 2015. Over the projection period, however, the wound care biologics market will be hampered by high treatment costs, a lack of awareness, and insufficient education and training.
Wound Care Biologics Market Segment Insights
The wound care biologics market has been segmented into product type, wound type, and end user.
Based on product type, has been segmented into biological skin substitutes and topical agents. The biological skin substitutes segment is expected to account for the largest share and fastest growing segment of the market in 2017.
The market, by wound type, has been segmented into ulcers, surgical & traumatic wounds, and burns. The ulcers segment has been further segmented into diabetic foot ulcers, pressure ulcers, venous leg ulcer, and others.
The market, by end user, has been segmented into hospitals, ambulatory surgical centers, and clinics.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The wound care biologics market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European wound care biologics market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The wound care biologics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The wound care biologics market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key players
Integra LifeSciences Corporation (US), Smith & Nephew (UK), Wright Medical (US), Mölnlycke Health Care AB (Sweden), MiMedx Group (US), Vericel Corporation (US), Anika Therapeutics (US), Osiris Therapeutics (US), Marine Polymer Technologies, Inc. (US), Kerecis (Iceland), Solsys Medical (US), ACell (US), and Organogenesis (US) are some of the key players in the wound care biologics market.
Regional Market Summary
Geographically, the Americas is anticipated to dominate the wound care biologics market owing to a well-developed healthcare sector, growing occurrences of chronic wounds, rising prevalence of diabetes and rising geriatric population. According to the National Diabetes Statistics Report 2017, about 30.3 million suffer from diabetes in Americans.
Europe is expected to hold the second largest position in the wound care biologics market. The market growth in this region is attributed to the increasing prevalence of diabetes and developed healthcare infrastructure.
The wound care biologics market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be the fastest growing region owing to the huge patient population of chronic diseases such as diabetes in countries such as India and China.
The Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector and growing government initiatives for the healthcare sector.
Wound Care Biologics Market Segmentation
Wound Care Biologics Market Product Type Outlook
- Skin Substitute
- Human Donor Tissue
- Acellular animal-derived
- Biosynthetic
- Topical Agents
Wound Care Biologics Market Wound Type Outlook
- Ulcers
- Diabetic foot ulcers
- Venous ulcers
- Pressure ulcers
- Other ulcers
- Surgical and Traumatic Wounds
- Burns
Wound Care Biologics Market End User Outlook
- Hospitals
- Clinics
- Other End Users
Wound Care Biologics Market Region Outlook
- Americas
-
- North America
- US
- Canada
- South America
- Europe
-
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Asia-Pacific
-
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- The Middle East & Africa
-
- Middle East
- Africa
Recent Development
Wright Medical Group Inc. manufactures human replacement components. The company creates replacement joints for the foot, ankle, hand, elbow, shoulder, and other damaged joints. The IN BONE, CLAW, and ORTHOLOC systems for foot and ankles, as well as the MICRONAIL implants for wrist fractures, are among the product lines. Wright's goods are distributed in over 60 countries, with the United States being the main market. Wright Medical Group N.V. was formed in 2015 when the company merged with Tornier of the Netherlands.
MiMedx Group Inc. is a medical equipment manufacturer. Biomaterials for soft tissue repair, such as tendons, ligaments, and cartilage, are the company's main emphasis, as well as various biomaterial-based solutions for other medical purposes. The MiMedx Group is a global provider of medical services.
Intended Audience
- Wound Care Biologics Manufacturers and Vendors
- Various Research and Consulting Firms
- Wound Care Biologics Distributors
- Hospitals
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
